ATE135113T1 - Synthetische hiv ähnliche peptide, deren zusammensetzungen und verwendungen - Google Patents

Synthetische hiv ähnliche peptide, deren zusammensetzungen und verwendungen

Info

Publication number
ATE135113T1
ATE135113T1 AT90901389T AT90901389T ATE135113T1 AT E135113 T1 ATE135113 T1 AT E135113T1 AT 90901389 T AT90901389 T AT 90901389T AT 90901389 T AT90901389 T AT 90901389T AT E135113 T1 ATE135113 T1 AT E135113T1
Authority
AT
Austria
Prior art keywords
hiv
peptides
antibodies
linked
peptide
Prior art date
Application number
AT90901389T
Other languages
English (en)
Inventor
Carl Formoso
Duane A Olsen
Thomas M Buchanan
Original Assignee
Clarity Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clarity Technologies Inc filed Critical Clarity Technologies Inc
Application granted granted Critical
Publication of ATE135113T1 publication Critical patent/ATE135113T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT90901389T 1988-12-20 1989-12-15 Synthetische hiv ähnliche peptide, deren zusammensetzungen und verwendungen ATE135113T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28741288A 1988-12-20 1988-12-20

Publications (1)

Publication Number Publication Date
ATE135113T1 true ATE135113T1 (de) 1996-03-15

Family

ID=23102787

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90901389T ATE135113T1 (de) 1988-12-20 1989-12-15 Synthetische hiv ähnliche peptide, deren zusammensetzungen und verwendungen

Country Status (7)

Country Link
EP (1) EP0449955B1 (de)
JP (1) JP2994031B2 (de)
AT (1) ATE135113T1 (de)
AU (1) AU641375B2 (de)
CA (1) CA2005955C (de)
DE (1) DE68925909T2 (de)
WO (1) WO1990007119A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE468168B (sv) * 1990-02-20 1992-11-16 Replico Medical Ab Hiv-1, p24 peptider, diagnostiska antigener och foerfarande foer saerskiljande diagnostik av preliminaert hiv-1 positiva serumprov
DE4039925A1 (de) * 1990-12-14 1992-06-17 Behringwerke Ag Ausgewaehlte peptide des gruppenspezifischen antigens (gag) von humanem immundefizienzvirus (hiv), ihre herstellung und verwendung
US6479055B1 (en) 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
US5464933A (en) 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
US6017536A (en) * 1993-06-07 2000-01-25 Trimeris, Inc. Simian immunodeficiency virus peptides with antifusogenic and antiviral activities
CN1148578C (zh) * 1994-07-25 2004-05-05 罗切诊断学有限公司 免疫测定特异抗体的方法、所用试剂、抗原及其用途
EP0787191B2 (de) * 1994-10-20 2011-10-26 Institut Pasteur Nukleotiden-sequenzen aus retroviren-antigenen hiv-i gruppe (oder untergruppe) o
FR2732346B1 (fr) * 1995-03-27 1997-05-30 Centre Nat Rech Scient Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques inclus dans lesdites proteines, vecteurs d'expression exprimant lesdites proteines mutees et leurs applications
WO1996040763A2 (en) * 1995-06-07 1996-12-19 Abbott Laboratories Peptides for hiv-1 detection
EP0831873A4 (de) 1995-06-07 2002-07-17 Trimeris Inc Die behandlung von hiv und anderen viralen infektionen mit der kombinationstherapie
US6395541B1 (en) 1996-05-23 2002-05-28 The Rockefeller University Methods for the identification of compounds capable of inhibiting HIV-1 viral replication employing murine cell lines expressing human topoisomerase I
US6319504B1 (en) 1996-06-24 2001-11-20 University Of Maryland Biotechnology Institute Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
US6214540B1 (en) 1997-03-26 2001-04-10 University Of Maryland Biotechnology Institute Chemokines that inhibit immunodeficiency virus infection and methods based thereon
DE19720914A1 (de) * 1997-05-16 1998-11-19 Boehringer Mannheim Gmbh Verfahren zum Nachweis von HIV-Antikörpern und dazu verwendete Antigene
US6548631B1 (en) 1997-09-16 2003-04-15 BIOMéRIEUX, INC. Macrophage derived chemokine (MDC) as an anti-viral agent for the treatment and prevention of lentivirus infection
US6750008B1 (en) 1999-07-09 2004-06-15 Trimeris, Inc. Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission
US6623741B1 (en) 2000-02-29 2003-09-23 Trimeris, Inc. Methods and compositions for inhibition of membrane fusion-associated events including RSV transmission
RU2179980C2 (ru) * 2000-03-20 2002-02-27 Государственный научный центр вирусологии и биотехнологии "Вектор" Пептид-имитатор консервативного эпитопа белка gp41 вируса иммунодефицита человека типа 1, узнаваемого вируснейтрализующими моноклональными антителами 2f5 (варианты)
AUPS065002A0 (en) 2002-02-20 2002-03-14 Immunaid Pty Ltd Strategy for retroviral immunotherapy
PL1692516T3 (pl) 2003-10-24 2011-05-31 Immunaid Pty Ltd Sposób terapii
GT200800303A (es) 2007-12-24 2009-09-18 Combinacion anti-retroviral
HUE026456T2 (en) 2009-05-27 2016-05-30 Biotempus Ltd Methods of treating diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
EP0245362B1 (de) * 1985-10-24 1994-06-29 Ronald C. Kennedy Synthetische peptide und deren verwendung zur diagnose und impfung für aids und arc
US4812556A (en) * 1987-05-18 1989-03-14 Virovahl Synthetic peptide antigen for the detection of HIV-2 infection

Also Published As

Publication number Publication date
CA2005955C (en) 2000-10-24
EP0449955B1 (de) 1996-03-06
JP2994031B2 (ja) 1999-12-27
AU641375B2 (en) 1993-09-23
JPH04502325A (ja) 1992-04-23
DE68925909D1 (de) 1996-04-11
EP0449955A1 (de) 1991-10-09
AU4816690A (en) 1990-07-10
CA2005955A1 (en) 1990-06-20
EP0449955A4 (en) 1992-10-28
DE68925909T2 (de) 1996-11-14
WO1990007119A1 (en) 1990-06-28

Similar Documents

Publication Publication Date Title
DE68925909D1 (de) Synthetische hiv ähnliche peptide, deren zusammensetzungen und verwendungen
Allain et al. Serological markers in early stages of human immunodeficiency virus infection in haemophiliacs
ATE364621T1 (de) Hiv-peptide
AU600466B2 (en) Htlv-iii envelope peptides
NO881719D0 (no) Syntetisk hiv-2-antigen.
NZ211860A (en) Method for detection of hiv; test kit
PT649537E (pt) Imunoanalises para anticorpos anti-vhc utilizando antigenios com epitopos conformacionais
Blomberg et al. Identification of regions of HIV-1 p24 reactive with sera which give" indeterminate" results in electrophoretic immunoblots with the help of long synthetic peptides
DE3584035D1 (de) Nachweis von menschlichem cytomegalovirus-spezifischem igm.
Sarngadharan et al. Immunological properties of the Gag protein p24 of the acquired immunodeficiency syndrome retrovirus (human T-cell leukemia virus type III).
DE69013950D1 (de) Monoklonaler Antikörper zur Unterscheidung HIV-2-seropositiver von HIV-1-seropositiven Individuen.
ZA961647B (en) Human t-cell line infected with hiv-2 which secretes functionally intact hiv-2 gp 160
Tribe et al. Antibodies reactive with human immunodeficiency virus gag-coded antigens (gag reactive only) are a major cause of enzyme-linked immunosorbent assay reactivity in a blood donor population
AU608413B2 (en) Mouse monoclonal antibody (5-21-3) to human immunodeficiency virus gp41 protein
AU5454586A (en) A method for detecting htlv-iii neutralizing antibodies in sera
KR880014376A (ko) Hiv 특이 항원 영역의 모노클로날 항체 및 그 용법
Burgisser et al. Multicenter evaluation of new double-antigen sandwich enzyme immunoassay for measurement of anti-human immunodeficiency virus type 1 and type 2 antibodies
Hashida et al. Shortening of the window period in diagnosis of HIV-1 infection by simultaneous detection of p24 antigen and antibody IgG to p17 and reverse transcriptase in serum with ultrasensitive enzyme immunoassay
KR920701243A (ko) T-임파 추향성 레트로 비루스 모노크로날항체
EP0267622A3 (de) Verfahren zum Nachweis von Antikörper gegen Anti-Adult-T-Zellen-Leukämie-Virus
SE9101863D0 (sv) Peptider, diagnostiskt antigen, vaccinkomposition och foerfarande foer selektering av hiv-stammar
Kontio Sensitive one-step enzyme immunoassay for HIV-1 p24 antigen in human blood specimens and cell culture supernatants
KR850008620A (ko) Atl 바이러스 항체의 측정방법 및 시약
Chumakov et al. Improvement of methods for intratypic differentiation of polioviruses: I. Agar gel diffusion precipitation test with repeated addition of antigens for differentiation between wild and vaccine polioviruses types 1 and 2
CA2017021A1 (en) Diagnostic test for detecting antibodies directed against antigens of one or more related viruses

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties